“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...

The Basilica of the Sacred Heart of Jesus is mourning the loss of its pastor, the Very Rev. John T. Howren, V.F., who died ...

The current study explored how macronutrients in the host diet are involved in gut colonization and competition by V.

32 Biosciences, a gastrointestinal (GI)-focused biotechnology company pioneering gut mucosal-immune science to prevent and treat GI diseases, today announced that it will officially launch its $40 ...

"Beyond typical flu symptoms like fever, cough and body aches, warning signs include trouble breathing, chest pain, confusion ...

Gynecologists long viewed bacterial vaginosis as solely a women’s issue — until a study that treated their male partners, too ...

BTS V once suffered from heat hives, also known as cholinergic urticaria. Learn its symptoms, causes, treatment, and how to prevent sweat-triggered hives. Do you know the fact that your favourite BTS ...

NV-387, based on a novel mechanism of action, and a novel nanomedicine technology that defines a new class of drugs, is a first-in-class broad-spectrum antiviral drug. Viruses cannot escape NV-387 ...

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections In the fiscal year 2025, we have achieved a ...